| Hallmarks of cancer: The CRISPR generation C Moses, B Garcia-Bloj, AR Harvey, P Blancafort European Journal of Cancer 93, 10-18, 2018 | 121 | 2018 |
| Zinc fingers, TALEs, and CRISPR systems: a comparison of tools for epigenome editing CB Waryah, C Moses, M Arooj, P Blancafort Epigenome editing: methods and protocols, 19-63, 2018 | 102 | 2018 |
| Activating PTEN tumor suppressor expression with the CRISPR/dCas9 system C Moses, F Nugent, CB Waryah, B Garcia-Bloj, AR Harvey, P Blancafort Molecular Therapy-Nucleic Acids 14, 287-300, 2019 | 85 | 2019 |
| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... Oncotarget 7 (37), 60535, 2016 | 81 | 2016 |
| Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers JA Kretzmann, CW Evans, C Moses, A Sorolla, AL Kretzmann, E Wang, ... Chemical Science 10 (33), 7718-7727, 2019 | 40 | 2019 |
| Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing C Moses, SI Hodgetts, F Nugent, G Ben-Ary, KK Park, P Blancafort, ... Scientific reports 10 (1), 11393, 2020 | 18 | 2020 |
| Applications of CRISPR systems in respiratory health: Entering a new ‘red pen’era in genome editing C Moses, P Kaur Respirology 24 (7), 628-637, 2019 | 16 | 2019 |
| A hidden layer of structural variation in transposable elements reveals potential genetic modifiers in human disease-risk loci EJ van Bree, RLFP Guimarães, M Lundberg, ER Blujdea, JL Rosenkrantz, ... Genome research 32 (4), 656-670, 2022 | 13 | 2022 |
| Large-scale reconstitution of a retina-to-brain pathway in adult rats using gene therapy and bridging grafts: An anatomical and behavioral analysis SW You, M Hellström, MA Pollett, C LeVaillant, C Moses, PJ Rigby, ... Experimental Neurology 279, 197-211, 2016 | 13 | 2016 |
| Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer C Waryah, J Cursons, M Foroutan, C Pflueger, E Wang, R Molania, ... Advanced Science 10 (22), 2301802, 2023 | 10 | 2023 |
| The acquisition of target dependence by developing rat retinal ganglion cells C Moses, LPG Wheeler, CJ LeVaillant, A Kramer, M Ryan, GS Cozens, ... Eneuro 2 (3), 2015 | 7 | 2015 |
| The CRISPR road: from bench to bedside on an RNA-guided path B Garcia-Bloj, C Moses, P Blancafort Annals of Translational Medicine 3 (13), 2015 | 3 | 2015 |
| Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System B Garcia-Bloj, C Moses, F Nugent, CB Waryah, AR Harvey, P Blancafort CELL PRESS, 2019 | | 2019 |
| Manipulating expression of the gene PTEN in cancer and the central nervous system with genetic and epigenetic editing C Moses | | 2018 |
| Development of a polymeric agent for the in vivo delivery of CRISPR system to activate tumour suppressor genes J Kretzmann, C Evans, C Moses, AS Bardaji, A Kretzmann, E Wang, D Ho, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017 | | 2017 |
| CRISPR-like genome editing tool-mediated down regulation of CAMK2D: A potential role for epigenetics intervention in the treatment of cardiac hypertrophy J Constantine, A Sgro, C Moses, P Blancafort, L Hool Heart, Lung and Circulation 24, S177, 2015 | | 2015 |
